Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor (GIST): ACOSOG Z9000 (Alliance) intergroup phase 2 trial
- Citation:
- Ann Surg vol 258 (3) 422-429
- Year:
- 2013
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Book Volume:
- 3
- Parents:
- 453
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Ronald P. DeMatteo Karla V. Ballman Cristina R. Antonescu Christopher Corless Violetta Kolesnikova Margaret von Mehren Martin D. McCarter Jeffrey Norton Robert G. Maki Peter W.T. Pisters George D. Demetri Murray F. Brennan Kouros Owzar
- Networks:
- Study
- ACOSOG-Z9000
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Article